Everotas 0.25mg Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Everolimus (0.25mg)
Overview Everotas 0.25mg Tablet
Tacrolimus 0.25mg tablets prevent organ rejection following transplantation by modulating the immune system to facilitate organ acceptance. This medication is also employed adjunctively in treating certain cancers, including those affecting the breast, pancreas, lung, and kidney. Dosage and duration should strictly adhere to the physician's prescription. It can be administered with or without food, but consistent daily timing is crucial. Overdosage carries potentially severe consequences. Commonly reported side effects encompass infection, pyrexia, cough, lassitude, diarrhea, and upper respiratory tract infections. Persistent or bothersome side effects necessitate immediate medical attention. Allergic reactions (e.g., skin rash, dyspnea, cough, edema) require immediate reporting to your doctor. Seek immediate medical counsel for increased thirst or urination frequency, respiratory distress, cough, fever, or prior to receiving any vaccinations during treatment. Pre-existing conditions and concurrent medications must be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should inform their doctor before starting Tacrolimus. Regular monitoring via laboratory tests may be recommended by your doctor to assess the medication's effects. Fertility in both men and women may be affected; discuss family planning with your doctor.
Uses of Everotas 0.25mg Tablet
Preventing graft rejection in transplant recipients
Major Benefits of Everotas 0.25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the 0.25mg Everotas tablet whole; do not chew, crush, or break it. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Everotas 0.25mg Tablet:
- Infection
- Fever
- Cough
- Fatigue
- Diarrhea
- Upper respiratory tract infection
How to use Everotas 0.25mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Everotas 0.25mg Tablets can be ingested with or without food, although consistent timing is recommended.
How Everotas 0.25mg Tablet works:
Everotas 0.25mg tablets modulate the body's immune response, thereby inhibiting organ transplant rejection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Everotas 0.25mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Everotas 0.25mg tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Employing Everotas 0.25mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Everotas 0.25mg Tablets, a potential side effect of which is fatigue. This medication may induce tiredness, impacting driving capabilities.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Everotas 0.25mg tablets without requiring any dosage modification.
LiverCAUTION
Patients with hepatic impairment should use Everotas 0.25mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Everotas 0.25mg tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Everotas 0.25mg Tablet :
NA
Facts to Know About Everotas 0.25mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Macrolide-Lactam Antibiotics |
| Developing Good Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently